| Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells M Najlah, M Jain, KW Wan, W Ahmed, M Albed Alhnan, DA Phoenix, ... Journal of liposome research 28 (1), 74-85, 2018 | 24 | 2018 |
| Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activity JM Cross, N Gallagher, JH Gill, M Jain, AW McNeillis, KL Rockley, ... Dalton Transactions 45 (32), 12807-12813, 2016 | 20 | 2016 |
| Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies AN Carson R. Reynolds, Son Tran, Mohit Jain Vaccines 196, 2022 | 14 | 2022 |
| Rationalized Computer-Aided Design of Matrix-Metalloprotease-Selective Prodrugs M Jain, JJ Harburn, JH Gill, PM Loadman, RA Falconer, CA Mooney, ... Journal of medicinal chemistry 60 (10), 4496-4502, 2017 | 7 | 2017 |
| The T-type Calcium Channel Cav3. 1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway U Banderali, M Jain, S Thakur, A Jayanthan, DD Belke, WR Giles, ... Current Eye Research, 1-10, 2021 | 4 | 2021 |
| Identification and in vitro validation of neoantigens for immune activation against high-risk pediatric leukemia cells S Thakur, M Jain, C Zhang, C Major, KJ Bielamowicz, NJ Lacayo, ... Human vaccines & immunotherapeutics, 1-5, 2021 | 3 | 2021 |
| Lin28A/let-7 oncogenic circuit is a potential therapeutic target in Neurocutaneous Melanosis associated CNS tumors in children AN Mohit Jain, Son Tran, Satbir Thakur, Yoji Nagashima, Ronald Anderson Neuro-Oncology Advances, 2020 | 3* | 2020 |
| In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors J Singer, EA Wachter, S Thakur, L Swift, C Zhang, M Jain, A Narendran US Patent 11,058,664, 2021 | 2 | 2021 |
| Pre-clinical evaluation of PV-10 for in vitro anti-tumor activity in refractory and high-risk adult solid tumors. S Tran, S Thakur, M Jain, C Zhang, A Narendran Journal of Clinical Oncology 39 (15_suppl), e14544-e14544, 2021 | 1 | 2021 |
| Development of Targeted Therapeutics for the Treatment of Glioblastoma M JAIN Durham University, 2017 | 1 | 2017 |
| Development of Liposome Drug Delivery Systems for Anti-Glioma Therapy ML Jain University of Central Lancashire, 2012 | 1 | 2012 |
| In Vitro and Xenograft Anti-Tumor Activity of a Halogenated-Xanthene Against Refractory Pediatric Solid Tumors J Singer, EA Wachter, S Thakur, L Swift, C Zhang, M Jain, A Narendran US Patent App. 17/344,418, 2021 | | 2021 |
| ATRT-09. IDENTIFICATION OF POTENTIAL GENETIC DRIVERS OF METHOTREXATE (MTX) RESISTANCE IN ATYPICAL TERATOID RHABDOID TUMOURS (ATRT) THROUGH A GENOME-WIDE RNAI SCREEN S Kannappan, M Gupa, SM Kang, AS Tran, SS Thakur, M Jain, ... Neuro-Oncology 23 (Supplement_1), i3-i3, 2021 | | 2021 |
| Preclinical evaluation of the ETS inhibitor TK216 against relapsed and refractory childhood leukemia. R Sharma, S Thakur, M Jain, C Zhang, AM Langevin, A Narendran Journal of Clinical Oncology 39 (15_suppl), 10033-10033, 2021 | | 2021 |
| A Novel Anti-Cancer Vaccine Approach for the Treatment of High-Risk Leukemia in Children T Satbir, S Tran, M Jain, A Lewis, L Murguia-Favela, FM Khan, ... BLOOD 136, 2020 | | 2020 |
| Development of Paclitaxel Loaded Ethanol-Based Proliposome Delivery Systems For The Treatment of Brain Tumour M Najlah, M Jain, W Ahmed, KW Wan, A Elhissi | | 2016 |
